Member Info for Faxandtheinfinit

None of the above!!!!

Who is thinking about a ground breaking 1100 RNS ??? On license, buyout or none of the above !! = spooky!!

Maybe the RNS will statecwe have been brought out 2 lol — Hopefully triple $1.9 billion

Hopefully 737 milestone payment’s will be fast coming our way now it’s been a long time wait!! If we are not next to be taken out makes prefect sense all under GSK good luck onwards and upwards,, Covid pill coming,, the world will soon know what we got xx

A few 1 trades = spooky

Obviously it makes prefect sense that II are buying in..At this price who wouldn’t.. need a TR1 to prove it …long may it continue?? Go for it SAR

Silence is golden in this game??? Also very boring come CPX get a wriggle on!!!!

ICL1960. All joking aside I would love to worry about that lol x

Yes, well over due rise, Tox report that separates SAR from most of not all didn’t even create a stir??? Still plenty more upside to come IMO..??

Just wondering is there any evidence of PEEL HUNT preforming yet or are we still waiting for institutional investment?? Just thinking buys would be bigger and no TR1s yet spooky!!

The frenzy you will get at braveheart is angina!

Yes got to reach £Billion Market Cap with on licensing 1801 in one indication surely.. CTA or FSA approval would see positive movement also BOD must be nearly ready to Let the RNSs go?? It’s been pretty quiet of late GLA

I wouldn’t hold your breath on that one 308 I’ve been resuscitated 86 times wait for that lol come on SAR

SIERRAs Market Cap to hit 1 Billon soon— how long before Sareums hits a billion hmmm come on SAR!

What is a joke is the Market Cap on this very day at this very moment!!

Has the court ruled in favour of CPX slightly confused? I’m assuming RNS update next week?

Hope that’s not an April fools insiderinfo lol

RNS 21st Feb 22

The bit I like is:

The CTA is expected to be filed during mid-2022??

Are we entering mid 2022 all be it early when trials are said to start in H2 2022???? RNS for CTA could be soon?

SDC-1801 (autoimmune diseases and severe Covid-19)

• Progress made advancing SDC-1801 towards clinical development as a potential treatment for autoimmune diseases and the acute respiratory symptoms of Covid-19

• Final toxicology and safety studies required to file for an exploratory Clinical Trial Authorisation ("CTA") were successfully completed in Q4 2021, and the final report is expected in Q1 2022

• Preliminary findings from these studies continue to support Sareum's plans to enter SDC-1801 into a first-in-human (Phase 1a) clinical study in healthy volunteers, and allow selection of an initial dose range

• The CTA is expected to be filed during mid-2022

• The synthesis of SDC-1801 drug substance under GMP conditions for formulating as an oral capsule is nearing completion. Development of the capsule formulation, also under GMP, intended for use in the Phase 1 trial is progressing to plan

• Planning for first clinical study is underway and the trial is expected to begin in H2 2022, subject to CTA approval and drug product supply

No April fool about a RNS stating SAR has been brought for £10 billion dam it lol

That song by ‘The Animals’ plays in my head when I look at ‘Sunrise loads of resources’ that they can’t sell…… spooky!!!!